89 related articles for article (PubMed ID: 23147652)
1. Gene polymorphisms of interleukin-17 and interleukin-17 receptor are associated with end-stage kidney disease.
Kim YG; Kim EY; Ihm CG; Lee TW; Lee SH; Jeong KH; Moon JY; Chung JH; Kim YH
Am J Nephrol; 2012; 36(5):472-7. PubMed ID: 23147652
[TBL] [Abstract][Full Text] [Related]
2. Association between interleukin 17/interleukin 17 receptor gene polymorphisms and papillary thyroid cancer in Korean population.
Lee YC; Chung JH; Kim SK; Rhee SY; Chon S; Oh SJ; Hong IK; Eun YG
Cytokine; 2015 Feb; 71(2):283-8. PubMed ID: 25484349
[TBL] [Abstract][Full Text] [Related]
3. Association between single nucleotide polymorphisms IL17RA rs4819554 and IL17E rs79877597 and Psoriasis in a Spanish cohort.
Batalla A; Coto E; González-Lara L; González-Fernández D; Gómez J; Aranguren TF; Queiro R; Santos-Juanes J; López-Larrea C; Coto-Segura P
J Dermatol Sci; 2015 Nov; 80(2):111-5. PubMed ID: 26347322
[TBL] [Abstract][Full Text] [Related]
4. Association between the IL17RA rs4819554 polymorphism and reduced renal filtration rate in the Spanish RENASTUR cohort.
Coto E; Gómez J; Suárez B; Tranche S; Díaz-Corte C; Ortiz A; Ruiz-Ortega M; Coto-Segura P; Batalla A; López-Larrea C
Hum Immunol; 2015 Mar; 76(2-3):75-8. PubMed ID: 25636567
[TBL] [Abstract][Full Text] [Related]
5. Role of non-HLA genetic variants in end-stage renal disease.
Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 gene cluster polymorphisms are associated with nutritional status and inflammation in patients with end-stage renal disease.
Maruyama Y; Nordfors L; Stenvinkel P; Heimburger O; Bárány P; Pecoits-Filho R; Axelsson J; Hoff CM; Holmes CJ; Schalling M; Lindholm B
Blood Purif; 2005; 23(5):384-93. PubMed ID: 16088107
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure.
Buraczynska M; Ksiazek P; Kubit P; Zaluska W
Cytokine; 2006 Nov; 36(3-4):167-72. PubMed ID: 17224277
[TBL] [Abstract][Full Text] [Related]
8. Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease.
Reiterová J; Merta M; Stekrová J; Cabartová Z; Cibulka R; Maixnerová D; Rysavá R; Ríhová Z; Tesar V; Motán J
Kidney Blood Press Res; 2006; 29(3):182-8. PubMed ID: 16943682
[TBL] [Abstract][Full Text] [Related]
9. Common variants in IL-17A/IL-17RA axis contribute to predisposition to and progression of congestive heart failure.
Sandip C; Tan L; Huang J; Li Q; Ni L; Cianflone K; Wang DW
Medicine (Baltimore); 2016 Jul; 95(27):e4105. PubMed ID: 27399111
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A
Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism in patients with end-stage renal failure.
Shu KH; Cheng CH; Wu MJ; Chen CH; Lee WC
Ren Fail; 2005; 27(1):53-7. PubMed ID: 15717635
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis.
Buraczynska M; Jozwiak L; Ksiazek P; Borowicz E; Mierzicki P
Transl Res; 2007 Aug; 150(2):101-5. PubMed ID: 17656329
[TBL] [Abstract][Full Text] [Related]
13. Prediction of susceptible biomarkers for end stage renal disease among North Indians.
Prakash S; Sarangi AN; Tripathi G; Sharma RK; Agrawal S
Nephrology (Carlton); 2016 Jul; 21(7):592-600. PubMed ID: 26421528
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes.
Craig DW; Millis MP; DiStefano JK
Diabet Med; 2009 Nov; 26(11):1090-8. PubMed ID: 19929986
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease.
Babel N; Gabdrakhmanova L; Hammer MH; Schoenemann C; Skrypnikov V; Poliak N; Volk HD; Reinke P
J Nephrol; 2006; 19(6):802-7. PubMed ID: 17173255
[TBL] [Abstract][Full Text] [Related]
16. Gene Polymorphisms of CD207 (Langerin) Are Associated With End-Stage Renal Disease.
Kim BW; Kang SW; Kim YH
Transplant Proc; 2016 Apr; 48(3):749-55. PubMed ID: 27234728
[TBL] [Abstract][Full Text] [Related]
17. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
[TBL] [Abstract][Full Text] [Related]
18. Effect of MDR1 gene polymorphism on progression of end-stage renal disease.
Zhang WX; Chen B; Zhang W; Chen N; Yu ZC; Cai WM
Acta Pharmacol Sin; 2007 Apr; 28(4):579-83. PubMed ID: 17376299
[TBL] [Abstract][Full Text] [Related]
19. Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis.
Spriewald BM; Witzke O; Wassmuth R; Wenzel RR; Arnold ML; Philipp T; Kalden JR
Ann Rheum Dis; 2005 Mar; 64(3):457-61. PubMed ID: 15708894
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor gene polymorphisms in North Indian patients with end stage renal disease.
Prakash S; Prasad N; Sharma RK; Faridi RM; Agrawal S
Cytokine; 2012 May; 58(2):261-6. PubMed ID: 22370607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
